Literature DB >> 9743188

Paradoxical reactions in HIV and pulmonary TB.

J W Chien1, J L Johnson.   

Abstract

We present a case of paradoxical clinical deterioration during antituberculosis therapy in an HIV-infected adult with pulmonary TB. The clinical course was characterized by marked cervical and mediastinal adenopathy accompanied by fever and weight loss during simultaneous treatment of TB and HIV disease. After extensive investigation for causes of therapeutic failure, the paradoxical reaction was attributed to partial immune reconstitution related to highly effective antiretroviral therapy. Due to the high prevalence of TB in HIV-infected patients, it is important to recognize this phenomenon and understand that it is usually self-limited.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9743188     DOI： 10.1378/chest.114.3.933

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  27 in total

1.  Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy.

Authors:  A Ramos; A Asensio; I Perales; M C Montero; T Martín
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-28       Impact factor: 3.267

2.  Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients.

Authors:  V C C Cheng; W C Yam; P C Y Woo; S K P Lau; I F N Hung; S P Y Wong; W C Cheung; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-24       Impact factor: 3.267

3.  Spontaneous splenic rupture as manifestation of the immune reconstitution inflammatory syndrome in an HIV type 1 infected patient with tuberculosis.

Authors:  E Weber; H F Günthard; T Schertler; J D Seebach
Journal:  Infection       Date:  2009-03-09       Impact factor: 3.553

4.  Clinical and radiological deterioration in a patient with AIDS.

Authors:  A I De Backer; K J Mortelé; P Bomans; B L De Keulenaer; I J Vanschoubroeck; M M Kockx
Journal:  Eur Radiol       Date:  2005-02-17       Impact factor: 5.315

5.  Integration of antiretroviral therapy with tuberculosis treatment.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L Gray; Tanuja Gengiah; Santhanalakshmi Gengiah; Anushka Naidoo; Niraksha Jithoo; Gonasagrie Nair; Wafaa M El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

6.  Tuberculosis-associated hemophagocytic lymphohistiocytosis with subsequent unmasking cryptococcal immune reconstitution inflammatory syndrome (IRIS) in an HIV-negative man.

Authors:  Hilte F Geerdes-Fenge; Micha Löbermann; Christoph J Hemmer; Orsolya Benedek; Emil C Reisinger
Journal:  Infection       Date:  2018-09-26       Impact factor: 3.553

7.  Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.

Authors:  Thanyawee Puthanakit; Peninnah Oberdorfer; Nuthapong Ukarapol; Noppadon Akarathum; Suchart Punjaisee; Thira Sirisanthana; Virat Sirisanthana
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

Review 8.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

9.  Cerebral Mycobacterium avium abscesses: Late immune reconstitution syndrome in an HIV-1-infected patient receiving highly active antiretroviral therapy.

Authors:  Claude Fortin; Danielle Rouleau
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

10.  Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.

Authors:  Joshua Baalwa; Harriet Mayanja-Kizza; Moses R Kamya; Laurence John; Andrew Kambugu; Robert Colebunders
Journal:  Afr Health Sci       Date:  2008-09       Impact factor: 0.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.